Body Chat Podcast · Dr. Stephen Nedd: Chiropractic Physician | Educator | Sharing Over 25 Years of Knowledge on Alternative Health Solutions & Ron Nedd - Author, Innovator, Podcast Host & Realtor®

Episode 297: DMSO – Topical and Oral Use…And Helping Autoimmune Conditions

·37 min·2 clips

In the 1967 Cleveland Clinic follow-up, 26 of 42 chronic scleroderma patients had good or excellent results.

Ron Nedd, a retired Twin Cities chiropractor now helping people buy and sell homes in the Tampa Bay and Los Angeles areas, opens the conversation with his brother, Dr. Stephen Nedd, who runs a chiropractic practice in the Clearwater area of Tampa Bay, Florida. The brothers frame the show as a weekly body chat about health, nutrition, exercise, and health care, and they remind listeners that neither of them is giving personal health advice. Stephen then continues the DMSO series by focusing on autoimmune conditions. The conversation keeps its usual posture: outside-the-box solutions first, conventional medicine under scrutiny. Stephen starts with scleroderma and the way DMSO was reported to affect the skin. He revisits older studies that describe skin becoming supple and ulcers healing. A March 1967 study is summarized as involving 45 patients, including people with psoriasis, keloid scars, and scleroderma. That report again pointed to major skin improvement. A follow-up study from January 1972, by the same researcher, looked at 20 patients and broadened the results beyond the skin. It was described as showing increased mobility, rapid pain relief, healing of persistent ulcers, stopping the spread of skin disease, hair regrowth, and the return of sweating and sensation in areas that had been numb. From there, Stephen shifts into circulation. He brings up a June 1983 study from Moscow that used dye to examine blood flow in skin and muscles. The researchers reportedly found that 50 percent DMSO helped a little, but adding 1 percent nicotinic acid, also called niacin or vitamin B3, increased circulation sixfold. The show says that combination helped resolve Raynaud's syndrome, gross edema, and hyperpigmentation. Stephen then widens the frame to rheumatoid arthritis and amyloidosis, saying DMSO was tried on about 2,500 people with those conditions and that the results were strong enough to get them out of the hospital. Another Russian study from 1974 follows, this one involving 52 women and six men with progressive, often severe scleroderma. They were given DMSO in concentrations from 30 to 90 percent, one to two times per day, for several months and sometimes up to two years. The episode keeps circling back to the idea that treatment had to be continued to keep the benefits going. It closes by looking ahead to the next installment, which will cover DMSO and eyes, ears, nose, throat, and dental issues. The hosts end by thanking listeners, inviting questions by email, and urging subscriptions on major podcast platforms.

As heard by us

A DMSO-heavy episode that leans on old studies and keeps its distrust of conventional medicine in plain view.

Body Chat follows DMSO through autoimmune claims, with scleroderma doing most of the lifting. Ron and Dr. Stephen Nedd keep leaning on specific studies, so the discussion stays tied to reports of softer skin, healed ulcers, better mobility, pain relief, better circulation, and…

Read the full review in PlayNext →

Why you'd press play

You want the DMSO case laid out through autoimmune studies, not wellness fluff.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Body Chat Podcast